Delivery Order SPE2DB20D6037-SPE2DB23FD0RC

Award Date 8/7/23
Potential Completion Date 8/8/23
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,265.48 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the pharmaceutical product Procainamide 1,000 mg/10 ml syringe, 10 ml. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,776.50 contract is for the delivery of 4,558,205,554 vials of 1 gram/10 ml procainamide, a prescription medication. The award is part of a larger single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,605.15, is for the provision of Procainamide Hydrochloride Injection USP to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of Procainamide Hydrochloride Injection USP, a medication used to treat certain heart rhythm disorders. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,132.00, is for the delivery of 4567916212 - PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML to support the medical supply needs of military health facilities. The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. also holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4562048894 - Procainamide 1 Gram/10 ML Vial 10ML. The contract has a ceiling value of $1,530.61 and an ultimate completion date of August 21, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which supports the recurring...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,277.81 contract is for the delivery of Procainamide Hydrochloride, a pharmaceutical product, with a completion date of December 13, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,605.15 contract is for the delivery of Procainamide Hydrochloride Injection USP, a type of pharmaceutical product, to support the recurring medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,210.30 award is for the supply of procainamide hydrochloride injection USP, a medication used to treat certain heart rhythm disorders. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,605.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract, which has no set-aside designation, is for the provision of procainamide hydrochloride injection USP, a medication primarily used to treat certain heart rhythm disorders. DMS Pharmaceutical Group holds a significant indefinite delivery...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB23FD0RC
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,155.02, is for the delivery of Procainamide 1 gram/10 ml vial (10 ml) to support the recurring medical supply needs of military health facilities.

The delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which is valued at up to $499,999,999 and runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, from common medications to specialized drugs and medical supplies, to fulfill the diverse medical requirements of Department of Defense (DoD) healthcare facilities worldwide. This contract has no set-aside designation.

Generated 10/23/24, 9:03 AM